← All trials
NCT05629559
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 16, 2022
- Primary completion
- May 31, 2024
- Completion date
- May 31, 2028
- First posted
- Nov 29, 2022
- Last posted
- Nov 29, 2022
- Enrollment
- 18
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- 4D Molecular TherapeuticsLead sponsor
- 4D Molecular TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.